Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for ...

Retrieved on: 2025-02-05 16:54:00

Tags for this article:

COVID-19 drug development

COVID-19 vaccination in the United States

RNA vaccines

Nitriles

Remdesivir

SARS-CoV-2 Omicron variant

Pfizer-BioNTech COVID-19 vaccine

COVID-19

SARS-CoV-2 Delta variant

Moderna COVID-19 vaccine

COVID-19 drug repurposing research

COVID-19 pandemic in the United States

Click the tags to see associated articles and topics

Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for .... View article details on hiswai:

Excerpt

Remdesivir is an IV formulation that can be conveniently used in hospitalized patients who cannot take nirmatrelvir/ritonavir compared to outpatients.

Article found on: bmcinfectdis.biomedcentral.com

View Original Article